Aster DM Healthcare Limited (NSE:ASTERDM)
India · Delayed Price · Currency is INR 813.75
+0.85 (0.10%)
Jun 11, 2026, 3:30 PM IST
Aster DM Healthcare Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Aster DM Healthcare stock has a consensus rating of "Buy" and an average price target of ₹795.27. The average 1-year stock price forecast is 2.27% lower than the current stock price, while the lowest is ₹743.00 (-8.69%) and the highest is ₹890.00 (+9.37%).
Price Target: ₹795.27 (-2.27%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Aster DM Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 5 |
| Buy | 4 | 4 | 3 | 4 | 4 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 9 | 10 | 11 |
Financial Forecast
Revenue This Year
107.76B
from 46.43B
Increased by 132.09%
Revenue Next Year
131.13B
from 107.76B
Increased by 21.68%
EPS This Year
13.99
from 7.04
Increased by 98.55%
EPS Next Year
19.15
from 13.99
Increased by 36.94%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 111.8B | ||
| Avg | 107.8B | ||
| Low | 100.1B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 140.8% | ||
| Avg | 132.1% | ||
| Low | 115.7% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 13.99 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 98.6% | ||
| Low | - |